DIAZABENZO[DE] ANTHRACEN-3-ONE COMPOUNDS AND METHODS FOR INHIBITING PARP
    34.
    发明申请
    DIAZABENZO[DE] ANTHRACEN-3-ONE COMPOUNDS AND METHODS FOR INHIBITING PARP 有权
    DIAZABENZO [DE] ANTHRACEN-3-ONE化合物和抑制PARP的方法

    公开(公告)号:US20130345225A1

    公开(公告)日:2013-12-26

    申请号:US13914067

    申请日:2013-06-10

    申请人: Eisai Inc.

    摘要: The present invention relates to diazabenzo[de]anthracen-3-one compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.

    摘要翻译: 本发明涉及抑制聚(ADP-核糖)聚合酶(“PARP”)的二氮杂苯并[de]蒽-3-酮化合物,含有这些化合物的组合物和使用这些PARP抑制剂治疗,预防和/或改善 本文所述条件的效果。

    CYP1B1 NUCLEIC ACIDS AND METHODS OF USE
    38.
    发明申请
    CYP1B1 NUCLEIC ACIDS AND METHODS OF USE 审中-公开
    CYP1B1核酸及其使用方法

    公开(公告)号:US20120201843A1

    公开(公告)日:2012-08-09

    申请号:US13423969

    申请日:2012-03-19

    IPC分类号: A61K39/00 A61P35/00 C12N15/53

    CPC分类号: C12N9/0077

    摘要: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.

    摘要翻译: 本发明提供含有编码CYP1B1多肽或其部分的转录单位的核酸,其中转录单位缺少在非翻译区(UTR)中发现CYP1B1转录本天然存在形式的序列。 本发明的核酸缺乏翻译阻遏物元件,因此提供了CYP1B1多肽或其部分的增强翻译的系统。 还公开了向哺乳动物施用核酸并用于治疗增殖性疾病或癌症的方法。